These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Ramakrishnan S; Houston LL Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765 [TBL] [Abstract][Full Text] [Related]
5. Toxicity, biological activity, and pharmacokinetics of TXU (anti-CD7)-pokeweed antiviral protein in chimpanzees and adult patients infected with human immunodeficiency virus. Uckun FM; Bellomy K; O'Neill K; Messinger Y; Johnson T; Chen CL J Pharmacol Exp Ther; 1999 Dec; 291(3):1301-7. PubMed ID: 10565855 [TBL] [Abstract][Full Text] [Related]
6. Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamide. Jansen B; Kersey JH; Jaszcz WB; Gunther R; Nguyen DP; Chelstrom LM; Tuel-Ahlgren L; Uckun FM Leukemia; 1993 Feb; 7(2):290-7. PubMed ID: 7678881 [TBL] [Abstract][Full Text] [Related]
7. Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. Terenzi A; Bolognesi A; Pasqualucci L; Flenghi L; Pileri S; Stein H; Kadin M; Bigerna B; Polito L; Tazzari PL; Martelli MF; Stirpe F; Falini B Br J Haematol; 1996 Mar; 92(4):872-9. PubMed ID: 8616080 [TBL] [Abstract][Full Text] [Related]
8. Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials. Myers DE; Irvin JD; Smith RS; Kuebelbeck VM; Uckun FM J Immunol Methods; 1991 Feb; 136(2):221-37. PubMed ID: 1705571 [TBL] [Abstract][Full Text] [Related]
9. Large scale manufacturing of TXU(anti-CD7)-pokeweed antiviral protein (PAP) immunoconjugate for clinical trials. Myers DE; Jun X; Clementson D; Donelson R; Sicheneder A; Hoffman N; Bell K; Sarquis M; Langlie MC; Turner N; Uckun FM Leuk Lymphoma; 1997 Oct; 27(3-4):275-302. PubMed ID: 9402326 [TBL] [Abstract][Full Text] [Related]
10. Pokeweed antiviral protein isoforms PAP-I, PAP-II, and PAP-III depurinate RNA of human immunodeficiency virus (HIV)-1. Rajamohan F; Venkatachalam TK; Irvin JD; Uckun FM Biochem Biophys Res Commun; 1999 Jul; 260(2):453-8. PubMed ID: 10403789 [TBL] [Abstract][Full Text] [Related]
11. Immunoconjugates that neutralize HIV virions kill T cells infected with diverse strains of HIV-1. Kim YW; Fung MS; Sun NC; Sun CR; Chang NT; Chang TW J Immunol; 1990 Feb; 144(4):1257-62. PubMed ID: 2303707 [TBL] [Abstract][Full Text] [Related]
12. Immunotoxins to a human melanoma-associated antigen: resistance to pokeweed antiviral protein conjugates in vitro. Morgan AC; Bordonaro J; Pearson JW; Sivam G J Natl Cancer Inst; 1987 Jun; 78(6):1101-6. PubMed ID: 3473251 [TBL] [Abstract][Full Text] [Related]
13. Immunological and biological stability of immunotoxins in vivo as studied by the clearance of disulfide-linked pokeweed antiviral protein-antibody conjugates from blood. Ramakrishnan S; Houston LL Cancer Res; 1985 May; 45(5):2031-6. PubMed ID: 3986759 [TBL] [Abstract][Full Text] [Related]
14. Ribosomal inhibitory proteins from plants inhibit HIV-1 replication in acutely infected peripheral blood mononuclear cells. Olson MC; Ramakrishnan S; Anand R AIDS Res Hum Retroviruses; 1991 Dec; 7(12):1025-30. PubMed ID: 1725958 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies. Ramakrishnan S; Houston LL Cancer Res; 1984 Jan; 44(1):201-8. PubMed ID: 6140077 [TBL] [Abstract][Full Text] [Related]
17. Deguanylation of human immunodeficiency virus (HIV-1) RNA by recombinant pokeweed antiviral protein. Rajamohan F; Kurinov IV; Venkatachalam TK; Uckun FM Biochem Biophys Res Commun; 1999 Sep; 263(2):419-24. PubMed ID: 10491308 [TBL] [Abstract][Full Text] [Related]
18. Actions of pokeweed antiviral protein on virus-infected protoplasts. Watanabe K; Kawasaki T; Sako N; Funatsu G Biosci Biotechnol Biochem; 1997 Jun; 61(6):994-7. PubMed ID: 9214760 [TBL] [Abstract][Full Text] [Related]
19. TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus. Uckun FM; Chelstrom LM; Tuel-Ahlgren L; Dibirdik I; Irvin JD; Langlie MC; Myers DE Antimicrob Agents Chemother; 1998 Feb; 42(2):383-8. PubMed ID: 9527790 [TBL] [Abstract][Full Text] [Related]
20. Favorable pharmacodynamic features and superior anti-leukemic activity of B43 (anti-CD19) immunotoxins containing two pokeweed antiviral protein molecules covalently linked to each monoclonal antibody molecule. Myers DE; Yanishevski Y; Masson E; Irvin JD; Evans WE; Uckun FM Leuk Lymphoma; 1995 Jun; 18(1-2):93-102. PubMed ID: 8580835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]